Should I Buy SGRP? SGRP 2026 Analysis

Should You Buy SPAR Group Inc (SGRP) Today? Analysis, Price Targets, and 2026 Outlook.

Conclusion

Sell

Latest Price

0.790

1 Day change

52 Week Range

2.030

Analysis Updated At

2026/01/30

Should I buy Analysis is updated weekly. For real time "Should I Buy" analysis, please sign up to get free answers.

SGRP is not a good buy right now. The trend is decisively bearish (moving averages stacked down and MACD worsening), and the latest quarter shows margin compression and a sharply larger net loss despite revenue growth. With no Intellectia buy signals, no fresh news catalysts, and weak forward pattern stats (negative bias over the next month), the risk/reward favors avoiding or exiting rather than buying.

Technical Analysis

Price/levels: SGRP is trading at ~0.797, sitting just above key support S1 (0.795) and above S2 (0.781). Immediate resistance is the pivot (0.817) then R1 (0.839). Trend: Bearish trend structure (SMA_200 > SMA_20 > SMA_5) signals sustained downside momentum. Momentum: MACD histogram is negative (-0.00326) and negatively expanding, suggesting bearish momentum is strengthening rather than stabilizing. RSI: RSI_6 at ~25 indicates short-term oversold conditions (bounce potential), but oversold can persist in downtrends. Pattern-based bias: Similar-pattern modeling implies modest upside next day/week (+1.26% / +0.68%) but a negative 1-month expectation (-1.42%), aligning with a broader bearish trend.

Intellectia Proprietary Trading Signals

AI Stock Picker: no signal on given stock today.
SwingMax: No signal on given stock recently.

Positive Catalysts

- Upcoming earnings (2026-02-13 pre-market) can act as a catalyst if results/forward commentary improve.
- Revenue grew +9.6% YoY in 2025/Q3, showing some top-line momentum.
- Oversold RSI may support a short-lived technical bounce near the 0.795–0.781 support band.

Neutral/Negative Catalysts

- Downtrend is firmly intact (bearish MA stack) and MACD bearish momentum is expanding.
- Profitability deteriorated materially: net income was -$8.764M in 2025/Q3 and EPS was -0.37, both far worse than the prior year despite the YoY ‘increase’ wording.
- Gross margin fell to 17.59% (down ~16.8% YoY), indicating weaker unit economics.
- No recent news flow to shift sentiment; hedge fund and insider activity are neutral (no supportive flow).
- No recent congress trading data available (no signal from influential political trading).

Financial Performance

Latest quarter: 2025/Q3.

Revenue: $41.416M, +9.60% YoY (top-line growth).
Gross margin: 17.59%, down ~16.79% YoY (margin compression).
Net income: -$8.764M (loss expanded sharply YoY based on the magnitude implied by +4715% YoY).
EPS: -0.37 (significantly worse YoY). Overall: growth in revenue is being outweighed by worsening profitability and weaker margins, which typically limits near-term upside appetite in a downtrending micro-cap.

Growth

Profitability

Efficiency

Analyst Ratings and Price Target Trends

No analyst rating or price target change data was provided, and there’s no recent news to infer a shift in Wall Street sentiment. With the available data, the ‘pros’ case is limited to revenue growth and a potential oversold bounce, while the ‘cons’ case (downtrend + worsening losses + margin decline) dominates the current setup.

Analyst Rating

Wall Street analysts forecast SGRP stock price to rise over the next 12 months. According to Wall Street analysts, the average 1-year price target for SGRP is 0 USD with a low forecast of 0 USD and a high forecast of 0 USD. However, analyst price targets are subjective and often lag stock prices, so investors should focus on the objective reasons behind analyst rating changes, which better reflect the company's fundamentals.

Buy

Hold